Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2

Status

Completed 6Terminated 1

Sponsor Class

OTHER 7INDUSTRY 4NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 14Gynecologic 7Gastrointestinal 5Other solid neoplasm 3CNS 3Breast 3Other hematologic neoplasm 2Genitourinary 2Sarcoma 1NET 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Ovarian Neoplasms 4Uterine Cervical Neoplasms 2Fallopian Tube Neoplasms 2Recurrence 1Ovarian Diseases 1Neoplasms by Site 1Neoplasms 1Endometrial Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma 1

Interventions

Paclitaxel 268Carboplatin 264Cisplatin 194Bevacizumab 135pembrolizumab 99Surveys and Questionnaires 84Radiotherapy 77Cyclophosphamide 75olaparib 67Blood Specimen Collection 65Drug Therapy 62Hyperthermic Intraperitoneal Chemotherapy 60Gemcitabine 60niraparib 56Topotecan 56Brachytherapy 54liposomal doxorubicin 52Taxes 47Docetaxel 46Magnetic Resonance Spectroscopy 43Letrozole 36Cytoreduction Surgical Procedures 36Filgrastim 33Biopsy 33Surgical Procedures, Operative 32durvalumab 31Specimen Handling 31Doxorubicin 31Nivolumab 30Albumin-Bound Paclitaxel 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × nintedanib × Gynecologic × Clear all
NCT02730416 2025-07-29

Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Completed
146 enrolled
Gynecologic

Endometrial Neoplasms

NCT02009579 2024-08-07

ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer

Belgian Gynaecological Oncology Group

Phase 2 Completed
120 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT01583322 2023-09-06

CHIVA

ARCAGY/ GINECO GROUP

Phase 2 Completed
188 enrolled
Gynecologic

Ovarian Neoplasms

NCT01485874 2022-02-15

Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer

Hoosier Cancer Research Network

Phase 1 Terminated
11 enrolled
Gynecologic

Ovarian Neoplasms

NCT01610869 2019-05-29

METRO-BIBF

University College, London

Phase 2 Completed
117 enrolled
Gynecologic

Carcinoma, Fallopian Tube Neoplasms, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Recurrence

NCT01669798 2018-10-16

BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer

Duke University

Phase 2 Completed
32 enrolled 19 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02835833 2018-07-10

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

University of Alabama at Birmingham

Phase 1 Completed
21 enrolled
GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡